Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
The eClinical Medicine of Lancet Published Phase 2 Results of Ivonescimab for the Treatment of NSCLC 2023-08-07 12:29
Ascentage Pharma Received Clearance from U.S. FDA to Proceed with Global Registrational Phase III Clinical Trial for Lisaftoclax (APG-2575) in Previously Treated Patients with CLL/SLL 2023-08-07 09:43
Shenzhen to Foster Quantitative Biology Stronghold 2023-08-03 19:00
JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology 2023-08-03 17:13
MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier 2023-08-03 16:00
ESMO 2023 | Ascentage Pharma to Present Results from Two Clinical Studies, including One Oral Presentation, at 2023 ESMO Congress 2023-08-03 11:43
SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation 2023-08-03 07:30
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting 2023-08-03 07:00
U.S. FDA Grants Orphan Drug Designation to ABM-1310 for the Treatment of Patients with Glioblastoma Harboring BRAF V600 Mutation 2023-08-03 00:00
Atantares has Completed Two Rounds of RMB100 Million Financing, and the Pre-A Round is led by Asia Green Fund 2023-08-02 14:56
Lunit Presents Groundbreaking Study on Predicting Treatment Response by HER2 Analysis in Colorectal Cancer 2023-08-01 21:00
Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use 2023-08-01 20:30
NEW AMAZFIT BIP 5 GOES BIGGER AND SMARTER WITH AN EXTRA-LARGE SCREEN, 70+ DOWNLOADABLE APPS AND GAMES, AND MORE 2023-08-01 20:00
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System 2023-08-01 20:00
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology 2023-08-01 19:00
Doer Biologics Announces First Subject Dosed in Phase I 12-Week Multiple-Ascending Dose (MAD) Clinical Trial of DR10624 and Received IND Approval From NMPA 2023-08-01 17:08
Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023 2023-08-01 01:00
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC 2023-08-01 00:00
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
Skincare Tech Brand AMIRO Receives QTL Certification from SGS to Strengthen R&D Efforts 2023-07-31 20:15
1 83 84 85 86 87 800